[
  {
    "EudraCT Number:": "2020-001636-95",
    "Sponsor Protocol Number:": "282110",
    "Sponsor Name:": "University of Manchester",
    "Full Title:": "Subcutaneous and Intravenous anakinra in COVID-19 Infection -  Feasibility & Pharmacokinetics/ Pharmacodynamics study",
    "Start Date:": "2020-05-20",
    "Medical condition:": "Suspected or confirmed SARS-CoV-2 infection (confirmed by RNA-PCR)",
    "Disease 1:": "Version: 23.0, SOC Term: 10021881 - Infections and infestations, Classification Code: 10051905, Term: Coronavirus infection, Level: PT",
    "Population Age:": "Adults, Elderly",
    "Gender:": "Male, Female",
    "Trial protocol:": "GB(GB - no longer in EU/EEA) ",
    "Link:": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001636-95",
    "Disease:": "",
    "Disease 2:": "",
    "Disease 3:": "",
    "Disease 4:": "",
    "COVID-19": ""
  },
  {
    "EudraCT Number:": "2020-001402-38",
    "Sponsor Protocol Number:": "CTU/2020/352",
    "Sponsor Name:": "University College London",
    "Full Title:": "An international, Bayesian platform adaptive, randomized, placebo-controlled trial assessing the effectiveness of candidate interventions in preventing COVID-19 disease in healthcare workers.",
    "Start Date:": "2020-10-20",
    "Medical condition:": "Coronavirus disease 2019 (COVID-19), also known as SARS-CoV-2 infection",
    "Disease 1:": "Version: 23.0, SOC Term: 10021881 - Infections and infestations, Classification Code: 10084268, Term: COVID-19, Level: PT",
    "Population Age:": "Adults, Elderly",
    "Gender:": "Male, Female",
    "Trial protocol:": "GB(GB - no longer in EU/EEA) ",
    "Link:": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001402-38",
    "Disease:": "",
    "Disease 2:": "",
    "Disease 3:": "",
    "Disease 4:": "",
    "COVID-19": ""
  },
  {
    "EudraCT Number:": "2020-001937-11",
    "Sponsor Protocol Number:": "132333",
    "Sponsor Name:": "University College London",
    "Full Title:": "A single-site, randomised, controlled, parallel design, open-label investigation of an approved nebulised recombinant human DNase enzyme (dornase alfa) to reduce hyperinflammation in hospitalised p...",
    "Start Date:": "2020-04-30",
    "Medical condition:": "Respiratory illness caused by Covid-19",
    "Disease 1:": "",
    "Population Age:": "Adults, Elderly",
    "Gender:": "Male, Female",
    "Trial protocol:": "GB(GB - no longer in EU/EEA) ",
    "Link:": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001937-11",
    "Disease:": "",
    "Disease 2:": "",
    "Disease 3:": "",
    "Disease 4:": "",
    "COVID-19": ""
  },
  {
    "EudraCT Number:": "2020-001640-26",
    "Sponsor Protocol Number:": "132151",
    "Sponsor Name:": "University College London",
    "Full Title:": "A pilot, open label, phase II clinical trial of nebulised recombinant tissue-Plasminogen Activator (rtPA)in patients with COVID-19 ARDS: The Plasminogen Activator COVID-19 ARDS (PACA) trial  ",
    "Start Date:": "2020-04-17",
    "Medical condition:": "Acute respiratory distress syndrome (ARDS) caused by COVID-19 ",
    "Disease 1:": "",
    "Population Age:": "Adults, Elderly",
    "Gender:": "Male, Female",
    "Trial protocol:": "GB(GB - no longer in EU/EEA) ",
    "Link:": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001640-26",
    "Disease:": "",
    "Disease 2:": "",
    "Disease 3:": "",
    "Disease 4:": "",
    "COVID-19": ""
  },
  {
    "EudraCT Number:": "2020-002668-29",
    "Sponsor Protocol Number:": "132796",
    "Sponsor Name:": "University College London",
    "Full Title:": "A Randomised Controlled Trial of plasma exchange with standard of care compared to standard of care alone in the treatment of severe COVID-19 infection (COVIPLEX)  ",
    "Start Date:": "2020-06-25",
    "Medical condition:": "COVID-19",
    "Disease 1:": "",
    "Population Age:": "Adults, Elderly",
    "Gender:": "Male, Female",
    "Trial protocol:": "GB(GB - no longer in EU/EEA) ",
    "Link:": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002668-29",
    "Disease:": "",
    "Disease 2:": "",
    "Disease 3:": "",
    "Disease 4:": "",
    "COVID-19": ""
  },
  {
    "EudraCT Number:": "2020-002106-68",
    "Sponsor Protocol Number:": "CTU/2020/354",
    "Sponsor Name:": "University College London Comprehensive Clinical Trial Unit",
    "Full Title:": "Favipiravir, lopinavir/ritonavir or combination therapy: a randomised, double blind, 2x2 factorial placebo-controlled trial of early antiviral therapy in COVID-19",
    "Start Date:": "2020-07-16",
    "Medical condition:": "SARS-CoV-2 (Corona virus) infection",
    "Disease 1:": "Version: 23.0, SOC Term: 100000004862, Classification Code: 10053983, Term: Corona virus infection, Level: LLT",
    "Population Age:": "Adults, Elderly",
    "Gender:": "Male, Female",
    "Trial protocol:": "GB(GB - no longer in EU/EEA) ",
    "Link:": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002106-68",
    "Disease:": "",
    "Disease 2:": "",
    "Disease 3:": "",
    "Disease 4:": "",
    "COVID-19": ""
  },
  {
    "EudraCT Number:": "2020-001072-15",
    "Sponsor Protocol Number:": "COV001",
    "Sponsor Name:": "University of Oxford",
    "Full Title:": "A phase I/II study to determine efficacy, safety and immunogenicity of the candidate Coronavirus Disease (COVID-19) vaccine ChAdOx1 nCoV-19 in UK healthy adult volunteers",
    "Start Date:": "2020-03-26",
    "Medical condition:": "COVID-19",
    "Disease 1:": "Version: 23.0, SOC Term: 10021881 - Infections and infestations, Classification Code: 10051905, Term: Coronavirus infection, Level: PT",
    "Population Age:": "Adults",
    "Gender:": "Male, Female",
    "Trial protocol:": "GB(GB - no longer in EU/EEA) ",
    "Link:": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001072-15",
    "Disease:": "",
    "Disease 2:": "",
    "Disease 3:": "",
    "Disease 4:": "",
    "COVID-19": ""
  },
  {
    "EudraCT Number:": "2020-001113-21",
    "Sponsor Protocol Number:": "NDPHRECOVERY",
    "Sponsor Name:": "University of Oxford",
    "Full Title:": "Randomised Evaluation of COVID-19 Therapy (RECOVERY)",
    "Start Date:": "2020-03-17",
    "Medical condition:": "COVID-19 (infection with SARS-CoV-2 virus)",
    "Disease 1:": "Version: 21.1, SOC Term: 10021881 - Infections and infestations, Classification Code: 10035737, Term: Pneumonia viral, Level: PT",
    "Population Age:": "Preterm newborn infants, Newborns, Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly",
    "Gender:": "Male, Female",
    "Trial protocol:": "GB(GB - no longer in EU/EEA) ",
    "Link:": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001113-21",
    "Disease:": "",
    "Disease 2:": "Version: 20.1, SOC Term: 10021881 - Infections and infestations, Classification Code: 10061982, Term: Severe acute respiratory syndrome, Level: PT",
    "Disease 3:": "",
    "Disease 4:": "",
    "COVID-19": ""
  },
  {
    "EudraCT Number:": "2020-001441-39",
    "Sponsor Protocol Number:": "VIR20001",
    "Sponsor Name:": "University of Oxford",
    "Full Title:": "Chloroquine/ hydroxychloroquine prevention of coronavirus disease (COVID-19) in the healthcare setting; a randomised, placebo-controlled prophylaxis study (COPCOV)",
    "Start Date:": "2020-05-12",
    "Medical condition:": "COVID-19, acute respiratory illness",
    "Disease 1:": "Version: 23.0, SOC Term: 100000004862, Classification Code: 10053983, Term: Corona virus infection, Level: LLT",
    "Population Age:": "Adults, Elderly",
    "Gender:": "Male, Female",
    "Trial protocol:": "GB(GB - no longer in EU/EEA) IT(Prematurely Ended) ",
    "Link:": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001441-39",
    "Disease:": "",
    "Disease 2:": "",
    "Disease 3:": "",
    "Disease 4:": "",
    "COVID-19": ""
  },
  {
    "EudraCT Number:": "2020-001889-10",
    "Sponsor Protocol Number:": "STOIC",
    "Sponsor Name:": "University of Oxford, Clinical Trials and Research Governance",
    "Full Title:": "Use of inhaled corticosteroids as treatment of early COVID-19 infection to prevent clinical deterioration and hospitalisation",
    "Start Date:": "2020-06-02",
    "Medical condition:": "COVID 19",
    "Disease 1:": "",
    "Population Age:": "Adults, Elderly",
    "Gender:": "Male, Female",
    "Trial protocol:": "GB(GB - no longer in EU/EEA) ",
    "Link:": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001889-10",
    "Disease:": "",
    "Disease 2:": "",
    "Disease 3:": "",
    "Disease 4:": "",
    "COVID-19": ""
  },
  {
    "EudraCT Number:": "2020-001740-26",
    "Sponsor Protocol Number:": "ATOMIC2",
    "Sponsor Name:": "University of Oxford, Clinical Trials and Research Governance",
    "Full Title:": "A multi-centre open-label two-arm randomised superiority clinical trial of Azithromycin versus usual care In Ambulatory COVID-19 (ATOMIC2)",
    "Start Date:": "2020-05-05",
    "Medical condition:": "COVID-19",
    "Disease 1:": "Version: 23.0, SOC Term: 10021881 - Infections and infestations, Classification Code: 10051905, Term: Coronavirus infection, Level: PT",
    "Population Age:": "Adults, Elderly",
    "Gender:": "Male, Female",
    "Trial protocol:": "GB(GB - no longer in EU/EEA) ",
    "Link:": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001740-26",
    "Disease:": "",
    "Disease 2:": "Version: 20.0, SOC Term: 10022891 - Investigations, Classification Code: 10070255, Term: Coronavirus test positive, Level: PT",
    "Disease 3:": "",
    "Disease 4:": "",
    "COVID-19": ""
  },
  {
    "EudraCT Number:": "2020-003628-18",
    "Sponsor Protocol Number:": "000000",
    "Sponsor Name:": "University of Oxford, Clinical Trials and Research Governance",
    "Full Title:": "Adalimumab in COVID-19 to present respiratory failure in community care (AVID-CC): A randomised controlled trial",
    "Start Date:": "2020-09-29",
    "Medical condition:": "COVID-19",
    "Disease 1:": "Version: 23.0, SOC Term: 10021881 - Infections and infestations, Classification Code: 10051905, Term: Coronavirus infection, Level: PT",
    "Population Age:": "Adults, Elderly",
    "Gender:": "Male, Female",
    "Trial protocol:": "GB(GB - no longer in EU/EEA) ",
    "Link:": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-003628-18",
    "Disease:": "",
    "Disease 2:": "Version: 20.0, SOC Term: 10022891 - Investigations, Classification Code: 10070255, Term: Coronavirus test positive, Level: PT",
    "Disease 3:": "",
    "Disease 4:": "",
    "COVID-19": ""
  },
  {
    "EudraCT Number:": "2020-001209-22",
    "Sponsor Protocol Number:": "PRINCIPLE",
    "Sponsor Name:": "University of Oxford / Clinical Trials and Research Governance ",
    "Full Title:": "Platform Randomised trial of INterventions against COVID-19 In older peoPLE",
    "Start Date:": "2020-03-26",
    "Medical condition:": "Suspected COVID-19",
    "Disease 1:": "Version: 23.0, SOC Term: 100000004862, Classification Code: 10053983, Term: Corona virus infection, Level: LLT",
    "Population Age:": "Adults, Elderly",
    "Gender:": "Male, Female",
    "Trial protocol:": "GB(GB - no longer in EU/EEA) ",
    "Link:": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001209-22",
    "Disease:": "",
    "Disease 2:": "",
    "Disease 3:": "",
    "Disease 4:": "",
    "COVID-19": ""
  },
  {
    "EudraCT Number:": "2020-002567-57",
    "Sponsor Protocol Number:": "1.0",
    "Sponsor Name:": "University of Oxford / Clinical Trials and Research Governance",
    "Full Title:": "To determine whether administration of almitrine bismesylate can ameliorate hypoxaemia in Covid-19 and augment effectiveness of supplementary oxygen therapy and respiratory support",
    "Start Date:": "2020-11-23",
    "Medical condition:": "Covid-19",
    "Disease 1:": "Version: 21.1, SOC Term: 10038738 - Respiratory, thoracic and mediastinal disorders, Classification Code: 10001053, Term: Acute respiratory failure, Level: PT",
    "Population Age:": "Adults, Elderly",
    "Gender:": "Male, Female",
    "Trial protocol:": "GB(GB - no longer in EU/EEA) ",
    "Link:": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002567-57",
    "Disease:": "",
    "Disease 2:": "",
    "Disease 3:": "",
    "Disease 4:": "",
    "COVID-19": ""
  },
  {
    "EudraCT Number:": "2020-001448-24",
    "Sponsor Protocol Number:": "RG_20-029COVID-19",
    "Sponsor Name:": "University of Birmingham",
    "Full Title:": "Preventing Pulmonary Complications in Surgical Patients at Risk of COVID-19 ",
    "Start Date:": "2020-04-15",
    "Medical condition:": "Preventing Pulmonary Complications in Surgical Patients at Risk of COVID-19",
    "Disease 1:": "Version: 20.0, SOC Term: 10021881 - Infections and infestations, Classification Code: 10035664, Term: Pneumonia, Level: PT",
    "Population Age:": "Adults, Elderly",
    "Gender:": "Male, Female",
    "Trial protocol:": "GB(GB - no longer in EU/EEA) ",
    "Link:": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001448-24",
    "Disease:": "",
    "Disease 2:": "Version: 21.1, SOC Term: 100000004855, Classification Code: 10003083, Term: ARDS, Level: LLT",
    "Disease 3:": "",
    "Disease 4:": "",
    "COVID-19": ""
  },
  {
    "EudraCT Number:": "2020-001684-89",
    "Sponsor Protocol Number:": "RG_20-030",
    "Sponsor Name:": "University of Birmingham",
    "Full Title:": "CATALYST - A randomised phase II proof of principle multi-arm multi-stage trial designed to guide the selection of interventions for phase III trials in hospitalised patients with COVID-19 infection.",
    "Start Date:": "2020-05-05",
    "Medical condition:": "COVID-19",
    "Disease 1:": "Version: 20.1, SOC Term: 100000004855, Classification Code: 10047468, Term: Viral lower respiratory tract infections, Level: HLT",
    "Population Age:": "Adolescents, Under 18, Adults, Elderly",
    "Gender:": "Male, Female",
    "Trial protocol:": "GB(GB - no longer in EU/EEA) ",
    "Link:": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001684-89",
    "Disease:": "",
    "Disease 2:": "",
    "Disease 3:": "",
    "Disease 4:": "",
    "COVID-19": ""
  },
  {
    "EudraCT Number:": "2020-004144-28",
    "Sponsor Protocol Number:": "CCTU0307",
    "Sponsor Name:": "Cambridge university Hosptials NHS Foundation Trust and University of Cambridge",
    "Full Title:": "PROphylaxis for paTiEnts at risk of COVID-19 infecTion",
    "Start Date:": "2020-10-23",
    "Medical condition:": "",
    "Disease 1:": "",
    "Population Age:": "",
    "Gender:": "",
    "Trial protocol:": "GB(GB - no longer in EU/EEA) ",
    "Link:": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-004144-28",
    "Disease:": "",
    "Disease 2:": "",
    "Disease 3:": "",
    "Disease 4:": "",
    "COVID-19": ""
  },
  {
    "EudraCT Number:": "2020-002230-32",
    "Sponsor Protocol Number:": "",
    "Sponsor Name:": "University of Edinburgh",
    "Full Title:": "Rapid Experimental Medicine for COVID-19 ",
    "Start Date:": "2020-06-23",
    "Medical condition:": "COVID-19",
    "Disease 1:": "",
    "Population Age:": "Under 18, Adults",
    "Gender:": "Male, Female",
    "Trial protocol:": "GB(GB - no longer in EU/EEA) ",
    "Link:": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002230-32",
    "Disease:": "",
    "Disease 2:": "",
    "Disease 3:": "",
    "Disease 4:": "",
    "COVID-19": ""
  },
  {
    "EudraCT Number:": "2020-001643-13",
    "Sponsor Protocol Number:": "01.01.20",
    "Sponsor Name:": "University of Dundee",
    "Full Title:": "A randomised double-blind placebo-controlled trial of Brensocatib (INS1007) in patients with severe COVID-19 ",
    "Start Date:": "2020-05-15",
    "Medical condition:": "COVID-19",
    "Disease 1:": "Version: 23.0, SOC Term: 10021881 - Infections and infestations, Classification Code: 10051905, Term: Coronavirus infection, Level: PT",
    "Population Age:": "Adolescents, Under 18, Adults, Elderly",
    "Gender:": "Male, Female",
    "Trial protocol:": "GB(GB - no longer in EU/EEA) ",
    "Link:": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001643-13",
    "Disease:": "",
    "Disease 2:": "",
    "Disease 3:": "",
    "Disease 4:": "",
    "COVID-19": ""
  },
  {
    "EudraCT Number:": "2020-003486-19",
    "Sponsor Protocol Number:": "1.002.20",
    "Sponsor Name:": "University of Dundee",
    "Full Title:": "A randomised, double-blind, placebo-controlled trial of SFX-01 or placebo on a backbone of best standard care, to improve outcomes in patients with community acquired pneumonia and suspected or con...",
    "Start Date:": "2020-10-08",
    "Medical condition:": "Community acquired pneumonia with suspected or confirmed SARS-CoV-2 infection",
    "Disease 1:": "Version: 20.1, SOC Term: 10021881 - Infections and infestations, Classification Code: 10066724, Term: Acute pneumonia, Level: LLT",
    "Population Age:": "Adults, Elderly",
    "Gender:": "Male, Female",
    "Trial protocol:": "GB(GB - no longer in EU/EEA) ",
    "Link:": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-003486-19",
    "Disease:": "",
    "Disease 2:": "Version: 20.1, SOC Term: 10021881 - Infections and infestations, Classification Code: 10010120, Term: Community acquired pneumonia, Level: LLT",
    "Disease 3:": "Version: 23.0, SOC Term: 10021881 - Infections and infestations, Classification Code: 10084380, Term: COVID-19 pneumonia, Level: PT",
    "Disease 4:": "Version: 21.1, SOC Term: 10038738 - Respiratory, thoracic and mediastinal disorders, Classification Code: 10001052, Term: Acute respiratory distress syndrome, Level: PT",
    "COVID-19": ""
  },
  {
    "EudraCT Number:": "2020-001860-27",
    "Sponsor Protocol Number:": "UoL001542",
    "Sponsor Name:": "University of Liverpool",
    "Full Title:": "AGILE: Seamless Phase I/IIa Platform for the Rapid Evaluation of Candidates for COVID-19 treatment",
    "Start Date:": "2020-05-12",
    "Medical condition:": "Coronavirus-induced disease (COVID-19) (SARS coronavirus 2, or SARS-CoV-2)",
    "Disease 1:": "Version: 23.0, SOC Term: 10021881 - Infections and infestations, Classification Code: 10051905, Term: Coronavirus infection, Level: PT",
    "Population Age:": "Adults, Elderly",
    "Gender:": "Male, Female",
    "Trial protocol:": "GB(GB - no longer in EU/EEA) ",
    "Link:": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001860-27",
    "Disease:": "",
    "Disease 2:": "",
    "Disease 3:": "",
    "Disease 4:": "",
    "COVID-19": ""
  },
  {
    "EudraCT Number:": "2020-002476-13",
    "Sponsor Protocol Number:": "20HH5958",
    "Sponsor Name:": "Imperial College London",
    "Full Title:": "A study to assess the safety and efficacy of Clazakizumab in patients with COVID-19 and kidney disease. ",
    "Start Date:": "2020-07-24",
    "Medical condition:": "Patients with kidney disease who are hospitalised with COVID-19 infection with pulmonary involvement (i.e. consistent chest imaging abnormalities) and clinical deterioration (i.e increasing oxygen ...",
    "Disease 1:": "Version: 20.0, SOC Term: 100000004857, Classification Code: 10023417, Term: Kidney dysfunction, Level: LLT",
    "Population Age:": "Adults, Elderly",
    "Gender:": "Male, Female",
    "Trial protocol:": "GB(GB - no longer in EU/EEA) ",
    "Link:": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002476-13",
    "Disease:": "",
    "Disease 2:": "Version: 20.0, SOC Term: 100000004862, Classification Code: 10047463, Term: Viral infection NOS, Level: LLT",
    "Disease 3:": "Version: 20.0, SOC Term: 10022891 - Investigations, Classification Code: 10063321, Term: Interleukin level, Level: PT",
    "Disease 4:": "Version: 20.1, SOC Term: 10041244 - Social circumstances, Classification Code: 10079637, Term: Dependence on oxygen therapy, Level: PT",
    "COVID-19": ""
  },
  {
    "EudraCT Number:": "2020-002494-10",
    "Sponsor Protocol Number:": "",
    "Sponsor Name:": "Queen Mary University of London",
    "Full Title:": "Personalised Electronic Record Supported OptimisatioN when ALone  for Patients with Hypertension- Pilot Study for Remote Medical Management of Hypertension During the COVID-19 Pandemic ",
    "Start Date:": "2020-07-17",
    "Medical condition:": "Hypertension",
    "Disease 1:": "Version: 21.1, SOC Term: 100000004866, Classification Code: 10081425, Term: Arterial hypertension, Level: LLT",
    "Population Age:": "Adults, Elderly",
    "Gender:": "Male, Female",
    "Trial protocol:": "GB(GB - no longer in EU/EEA) ",
    "Link:": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002494-10",
    "Disease:": "",
    "Disease 2:": "",
    "Disease 3:": "",
    "Disease 4:": "",
    "COVID-19": ""
  },
  {
    "EudraCT Number:": "2020-001331-26",
    "Sponsor Protocol Number:": "PROLIFIC2020",
    "Sponsor Name:": "Cambridge University Hospitals NHS Foundation Trust",
    "Full Title:": "ChemoPROphyLaxIs For covId-19 infeCtious disease (the PROLIFIC trial)",
    "Start Date:": "2020-04-14",
    "Medical condition:": "Coronavirus disease 2019 (COVID-19) caused by the infection, SARS-CoV-2",
    "Disease 1:": "Version: 20.0, SOC Term: 100000004862, Classification Code: 10051905, Term: Coronavirus infection, Level: LLT",
    "Population Age:": "Adults, Elderly",
    "Gender:": "Male, Female",
    "Trial protocol:": "GB(GB - no longer in EU/EEA) ",
    "Link:": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001331-26",
    "Disease:": "",
    "Disease 2:": "",
    "Disease 3:": "",
    "Disease 4:": "",
    "COVID-19": ""
  },
  {
    "EudraCT Number:": "2020-002229-27",
    "Sponsor Protocol Number:": "TACTIC-E",
    "Sponsor Name:": "Cambridge University Hospitals NHS Foundation Trust",
    "Full Title:": "mulTi-Arm Therapeutic study in pre-ICu patients admitted with Covid-19 \u2013 Experimental drugs and mechanisms  ",
    "Start Date:": "2020-06-09",
    "Medical condition:": "SARS-Cov-2",
    "Disease 1:": "",
    "Population Age:": "Adults, Elderly",
    "Gender:": "Male, Female",
    "Trial protocol:": "GB(GB - no longer in EU/EEA) ",
    "Link:": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002229-27",
    "Disease:": "",
    "Disease 2:": "",
    "Disease 3:": "",
    "Disease 4:": "",
    "COVID-19": ""
  },
  {
    "EudraCT Number:": "2020-001354-22",
    "Sponsor Protocol Number:": "TACTIC-R",
    "Sponsor Name:": "Cambridge University Hospitals NHS Foundation Trust",
    "Full Title:": "Multiarm Therapeutic study in pre-ICU patients admitted with COVID-19 - Repurposed Drugs (TACTIC-R)",
    "Start Date:": "2020-05-06",
    "Medical condition:": "COVID-19-related complications",
    "Disease 1:": "",
    "Population Age:": "Adults, Elderly",
    "Gender:": "Male, Female",
    "Trial protocol:": "GB(GB - no longer in EU/EEA) ",
    "Link:": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001354-22",
    "Disease:": "",
    "Disease 2:": "",
    "Disease 3:": "",
    "Disease 4:": "",
    "COVID-19": ""
  }
]